“A key to offering patients precision-medicine treatment”
Another global life-science company, Amgen, has moved to Hagastaden. Here, CEO Karin Järperud discusses their initiatives to strengthen clinical research, enhance patient benefits, and drive innovation. We also learn how they have work with the mentoring program together with Fryshuset – and how this has strengthened Amgen as well!
Karin Järperud, VD/Country Sr Director, and Ola Gelin, Communications and digital lead Sweden.
The global biotechnology company Amgen works to improve the lives of people living with serious illnesses. They have been active in Sweden since 1995 and are particularly involved in therapeutic areas such as oncology, hematology, inflammation, cardiometabolic diseases, and rare diseases.
– With a strong patient focus and a culture built on science, ethics, and collaboration, we strive to be a reliable partner for both healthcare and society at large, says Karin Järperud, Country Sr Director.
Current news from Stockholm Science City
